B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptide
-
- Target See all BCAP31 products
- BCAP31 (B-Cell Receptor-Associated Protein 31 (BCAP31))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCAP31 antibody (Catalog #: ARP46645_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCAP31 (B-Cell Receptor-Associated Protein 31 (BCAP31))
- Background
-
BCAP31 is a member of the B-cell receptor associated protein 31 superfamily. It is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in the caspase 8-mediated apoptosis. Microdeletions in this gene are associated with the contiguous ABCD1/DXS1375E deletion syndrome.
Alias Symbols: 6C6-AG, BAP31, CDM, DXS1357E
Protein Interaction Partner: PTPLB,ACTG1,APP,BCAP29,BCAP31,BCL2,BCL2L1,CANX,CASP1,CASP3,CASP8,HLA-A,MSN,MYH10,PLP2,PTPLB,VAMP1,VAMP3,ACTG1,BCAP29,BCAP31,BCL2,BCL2L1,CASP1,CASP8,MYH10,VAMP2,VAMP3
Protein Size: 246 - Molecular Weight
- 28 kDa
- Gene ID
- 10134
- NCBI Accession
- NM_005745, NP_005736
- UniProt
- P51572
-